本周（2026.02.23-2026.02.27）申万医药指数涨幅0.50%，沪深300指数涨幅1.08%，跑输沪深300指数0.58%，在申万31个一级行业指数中排名第25。截至本周五（2026.02.27）医药生物行业指数PE（TTM，剔除负值）为31.03倍，沪深300指数PE（TTM，剔除负值）为13.45倍，医药生物行业相较于沪深300指数的估值溢价率为130.65%，仍处于历史低位。...
Source Link本周（2026.02.23-2026.02.27）申万医药指数涨幅0.50%，沪深300指数涨幅1.08%，跑输沪深300指数0.58%，在申万31个一级行业指数中排名第25。截至本周五（2026.02.27）医药生物行业指数PE（TTM，剔除负值）为31.03倍，沪深300指数PE（TTM，剔除负值）为13.45倍，医药生物行业相较于沪深300指数的估值溢价率为130.65%，仍处于历史低位。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.